{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:19:07Z","timestamp":1783045147372,"version":"3.54.6"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574334"],"award-info":[{"award-number":["82574334"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031918","name":"State Key Laboratory of Natural and Biomimetic Drugs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031918","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFE0104300"],"award-info":[{"award-number":["2023YFE0104300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jconrel.2026.114972","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:50:53Z","timestamp":1777564253000},"page":"114972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Transformable nanoassembly of CXCL16 peptide-SN38 conjugate improves intratumor permeation and retention in peritoneal metastases"],"prefix":"10.1016","volume":"395","author":[{"given":"Yi","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuwei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingbo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfu","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyu","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.114972_bb0005","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41586-022-05402-9","article-title":"Metastatic recurrence in colorectal cancer arises from residual EMP1(+) cells","volume":"611","author":"Ca\u00f1ellas-Socias","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.114972_bb0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-32198-z","article-title":"Molecular characterization of colorectal cancer related peritoneal metastatic disease","volume":"13","author":"Lenos","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114972_bb0015","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1080\/17425247.2019.1693997","article-title":"Intraperitoneal delivery of chemotherapeutic agents for the treatment of peritoneal metastases: current challenges and how to overcome them","volume":"16","author":"Sugarbaker","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.114972_bb0020","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2020.31.e58","article-title":"Incidence and predictors of peritoneal metastases of gynecological origin: a population-based study in the Netherlands","volume":"31","author":"Burg","year":"2020","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.jconrel.2026.114972_bb0025","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","article-title":"Metastasis","volume":"186","author":"Gerstberger","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.114972_bb0030","first-page":"49","article-title":"The contemporary management of peritoneal metastasis: a journey from the cold past of treatment futility to a warm present and a bright future","volume":"73","author":"Foster","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2026.114972_bb0035","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejso.2020.01.032","article-title":"Prehabilitation of patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancy","volume":"47","author":"Cort\u00e9s-Guiral","year":"2021","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.jconrel.2026.114972_bb0040","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41571-022-00675-5","article-title":"Advances in the management of peritoneal malignancies","volume":"19","author":"Kepenekian","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.114972_bb0045","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1245\/s10434-025-17321-w","article-title":"Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS\/HIPEC) and liver-directed therapy for synchronous peritoneal and liver metastatic colorectal Cancer: a systematic review with meta-analysis","volume":"32","author":"Taqi","year":"2025","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.jconrel.2026.114972_bb0050","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.jconrel.2020.11.003","article-title":"Tumor-mesoporous silica nanoparticle interactions following intraperitoneal delivery for targeting peritoneal metastasis","volume":"328","author":"Hargrove","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114972_bb0055","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-021-00326-6","article-title":"Primary and metastatic peritoneal surface malignancies","volume":"7","author":"Cort\u00e9s-Guiral","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jconrel.2026.114972_bb0060","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.1002\/anie.202000947","article-title":"Tumor microenvironment-activated NIR-II nanotheranostic system for precise diagnosis and treatment of peritoneal metastasis","volume":"59","author":"Ling","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.114972_bb0065","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41571-021-00529-6","article-title":"The blood-tumour barrier in cancer biology and therapy","volume":"18","author":"Steeg","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.114972_bb0070","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ng.3225","article-title":"Stromal gene expression defines poor-prognosis subtypes in colorectal cancer","volume":"47","author":"Calon","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jconrel.2026.114972_bb0075","first-page":"493","article-title":"Microbiome dysbiosis, neutrophil recruitment and mesenchymal transition of mesothelial cells promotes peritoneal metastasis of colorectal cancer","volume":"6","author":"Li","year":"2025","journal-title":"Nat. Can."},{"key":"10.1016\/j.jconrel.2026.114972_bb0080","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.1021\/acs.nanolett.4c06402","article-title":"Rational design of bioinspired lipoprotein system to improve penetration in colorectal peritoneal metastases","volume":"25","author":"Chi","year":"2025","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.114972_bb0085","article-title":"Intraperitoneal administration of cabazitaxel-loaded nanoparticles in peritoneal metastasis models","volume":"48","author":"Hyldbakk","year":"2023","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.114972_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010829","article-title":"Peptide drug conjugates and their role in cancer therapy","volume":"24","author":"Heh","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.114972_bb0095","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1039\/D0CS00556H","article-title":"Peptides as a platform for targeted therapeutics for cancer: peptide-drug conjugates (PDCs)","volume":"50","author":"Cooper","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2026.114972_bb0100","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1021\/cr500171e","article-title":"Lutetium-177 therapeutic radiopharmaceuticals: linking chemistry, radiochemistry, and practical applications","volume":"115","author":"Banerjee","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2026.114972_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123402","article-title":"Design, synthesis and bioactivity investigation of peptide-camptothecin conjugates as anticancer agents with a potential to overcome drug resistance","volume":"645","author":"Zhang","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114972_bb0110","doi-asserted-by":"crossref","first-page":"8064","DOI":"10.1038\/s41467-023-43718-w","article-title":"Design and structural validation of peptide-drug conjugate ligands of the kappa-opioid receptor","volume":"14","author":"Muratspahi\u0107","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114972_bb0115","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2020.10.009","article-title":"Multifunctional peptides for tumor therapy","volume":"160","author":"Li","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114972_bb0120","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41571-021-00588-9","article-title":"Harnessing cytokines and chemokines for cancer therapy","volume":"19","author":"Propper","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.114972_bb0125","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41568-023-00635-w","article-title":"How chemokines organize the tumour microenvironment","volume":"24","author":"Mempel","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.114972_bb0130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2022.04.006","article-title":"Strategies of engineering nanomedicines for tumor retention","volume":"346","author":"Qian","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114972_bb0135","doi-asserted-by":"crossref","first-page":"15287","DOI":"10.1002\/anie.201908185","article-title":"In\u00a0situ self-assembled nanofibers precisely target cancer-associated fibroblasts for improved tumor imaging","volume":"58","author":"Zhao","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.114972_bb0140","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1021\/acs.nanolett.9b04752","article-title":"Photothermal-promoted morphology transformation in vivo monitored by photoacoustic imaging","volume":"20","author":"Zhang","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.114972_bb0145","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1021\/jacs.8b13512","article-title":"Autocatalytic morphology transformation platform for targeted drug accumulation","volume":"141","author":"Cheng","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.114972_bb0150","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1038\/s41467-019-12848-5","article-title":"A tumour-selective cascade activatable self-detained system for drug delivery and cancer imaging","volume":"10","author":"An","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114972_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113637","article-title":"In situ peptide assembly for cell membrane rewiring in tumor therapy","volume":"381","author":"Ma","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114972_bb0160","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/s41374-020-0448-x","article-title":"A mouse model for peritoneal metastases of colorectal origin recapitulates patient heterogeneity","volume":"100","author":"Bastiaenen","year":"2020","journal-title":"Lab. Investig."},{"key":"10.1016\/j.jconrel.2026.114972_bb0165","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jconrel.2024.07.017","article-title":"Intraperitoneal drug delivery systems for peritoneal carcinomatosis: bridging the gap between research and clinical implementation","volume":"373","author":"Perell\u00f3-Trias","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114972_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13061415","article-title":"Peptide-based nanoparticle for tumor therapy","volume":"13","author":"Thongpon","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.jconrel.2026.114972_bb0175","first-page":"260","article-title":"Fabrication of self-assembling nanofibers with optimal cell uptake and therapeutic delivery efficacy","volume":"2","author":"Xu","year":"2017","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.114972_bb0180","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ng.3224","article-title":"Stromal contribution to the colorectal cancer transcriptome","volume":"47","author":"Isella","year":"2015","journal-title":"Nat. Genet."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926003755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926003755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:49:30Z","timestamp":1783043370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926003755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":36,"alternative-id":["S0168365926003755"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114972","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transformable nanoassembly of CXCL16 peptide-SN38 conjugate improves intratumor permeation and retention in peritoneal metastases","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114972","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114972"}}